Three ACNU-resistant clones (R~, R3, and R.2) were isolated from 9L rat glioma cells under selection pressure of ACNU in vitro. The authors have investigated the mechanisms of resistance and characteristics of these clones at the cellular level by studying cross-resistance patterns to chemical and physical agents. Although these resistant sublines showed complete cross-resistance to methyl-chloroethylnitrosourea (MCNU), no crossresistance was observed for other alkylating agents, while each of the resistant sublines showed partial crossresistance to structurally dissimilar toxic agents (vinblastine, Adriamycin,. No difference in ACNU uptake was observed between 9L and R3 cells, and resistance patterns among alkylating agents suggested that the mechanism of ACNU resistance was specific to bifunctional nitrosoureas. Based on a transport study, this multidrug resistance could be explained by reduced intracellular uptake of these drugs, but there seemed little possibility that membrane P-glycoprotein, which usually is observed in typical multidrug-resistant cells, was expressed in these ACNU-resistant cells because enhanced drug effiux was not found in ACNU-resistant sublines. Significant collateral sensitivity to L-asparaginase indicated that ACNU might disturb the asparagine synthetic pathways by its mutagenic action. The increased level of total glutathione in the resistant sublines may be one mechanism of radiation or ACNU resistance.
T HE nitrosourea 1 -(4-amino-2-methyl-5-pyrimidinyl)-methyl-3-(2-chloroethyl)-3-nitrosourea hydrochloride (ACNU)-is a water-soluble derivative of chloroethylnitrosourea (CNU). This agent has been used commonly for treating brain tumors in Japan, and its clinical effectiveness has been documented. 34 However, its therapeutic efficacy is limited by intrinsic (natural) and drug-induced (acquired) resistance. ~4 Not all patients with a given tumor respond to anticancer compounds, including ACNU, and most patients who do respond eventually become refractory. Therefore, natural and acquired resistance are major obstacles to clinical treatment as well as major research challenges. To overcome these problems and to develop a more rational and effective anticancer strategy, understanding the mechanism of drug resistance is very important. It is plausible to speculate that ACNU may cause various cell modifications not associated directly with its cytotoxicity because this drug has strong mutagenic activity ~-'~ as well as cytotoxic effects.
We have developed rat glioma sublines that show stable resistance to ACNU in vitro. 29 Using these resistant sublines, we have investigated the phenotypic characteristics that ACNU-resistant sublines have gained with the acquisition of resistance to ACNU in studies of their cross-resistance patterns to chemical and physical agents.
Materials and Methods

Cell and Culture Preparation
The 9L rat glioma cell line 4 was developed in Fischer 344 rats by the administration of l-methyl-1-nitrosourea. Three ACNU-resistant cells (R~, R~, and R~2) were isolated from 9L cells under the selection pressure of ACNU and were cloned in vitro. ~-~ These cells were maintained in our laboratories in Ham's F-12 medium supplemented with 10% fetal bovine serum (FBS) and streptomycin (100 #g/ml). The cells were grown by monolayer culture methods at 37~ in a humidified chamber with 5% CO2 and 95% air and subcultured every 3 days. 
Assay of Toxicity to Chemical Agents
Exponentially growing cells were trypsinized with 0.1% trypsin for 5 minutes at 370C, a single-cell suspension was obtained by repeated pipetting, and viable cells were counted on a hemocytometer using the nigrosin dye-exclusion test. All chemicals were prepared freshly in distilled water or dimethyl sulfoxide before use.
The cytotoxic effects of all chemicals except L-asparaginase (L-ASP) were measured as follows: 2 x 102 to 2 x 10 ~ cells were plated in 60-mm plastic dishes, and after 24 hours of incubation, these cells were treated with various concentrations of chemicals for 2 hours. The chemical-containing medium was then replaced by fresh medium, and the cells were incubated for 12 to Y. Saito, el al. 14 days before fixation with methanol and staining with 3% Giemsa solution. Colonies of more than 50 cells were counted, and the surviving fraction was estimated as the ratio of the colony-forming efficiency of treated cells to that of untreated cells. The mean lethal dose to kill 37% of the population (inhibiting concentration, 1C3:) was calculated from the linear region of the doseresponse curves. Relative resistance was determined by dividing the IC37 of the ACNU-resistant sublines by the IC,7 of the parental 9L cells. The IC~: was the mean of at least three separate experiments using the same batch of FBS.
The cytotoxic effect of L-ASP was quantified as follows. Four hours after 1 x 10 -~ cells were plated in 35-mm plastic dishes, the culture medium was replaced by an L-ASP-containing medium. Every 24 hours thereafter, cells from triplicate dishes were sampled separately and counted using the nigrosin dye-exclusion test. The minimum concentrations of L-ASP that inhibited the growth of 9L or resistant cells completely was employed as an index of sensitivity to L-ASP.
Assay of X-Ray and Ultraviolet Sensitivity
A Shimazu x-ray generator, operated at 200 kVp, 25 mA, with 0.5-ram Cu and 1.0-mm A I screen filtration, was used for irradiation. Cells growing exponentially were diluted in a tube with medium (1 x 105 cells/ml) and were irradiated at room temperature under aerobic conditions at a rate of 0.86 Gy/min. Immediately after irradiation, 2 x 10-" to 5 x 104 cells were seeded in 60mm plastic dishes and incubated. After 12 to 14 days, colonies were counted as described previously. Using the linear portion of the curves, we performed a leastsquares regression analysis of the individual dose data points for each cell line to generate radiation survival curves. Conventionally, two parameters have been used to describe the radiation survival curves: Do, the slope Cross-resistance patterns in ACNU-resislant gliomas of the exponential portion of the curve that shows the dose required to reduce cell survival to 37%: and D,,. a measure of the width of the shoulder of the curve. calculated by extrapolating the straight portion of the curves back to the x-axis.
For ultraviolet (UV) light cell survival assays, exponentially growing cells (2 x 10~" to 2 x 10 ~) were seeded in 60-ram plastic dishes and incubated. After 24 hours. the medium was aspirated and washed with phosphatebuffered saline (PBS); these plates were UV-irradiated with a 15-W germicidal lamp (254 nm) at an intensity of 1.0 J/sq m/see. The values for D,, and D~ were determined from the dose-survival curves as described for the x-ray sensitivity assay.
Assay (f ThermosensitiviO,
For hyperthermia studies, exponentially growing cells (2 x 102to 5 x 104) were plated in 60-ram plastic dishes and incubated at 37~ for 2 hours. The dishes were then heated in a humidified chamber with 5% CO2 and 95% airat 40 ~ 4i ~ 42 ~ 43 ~ or 44~ for 0.5 to 3 hours. After heating, cells were reincubated at 37"C for 12 to 14 days. The surviving fraction was estimated as the ratio of the colony-forming efficiency of heated cells to that of unheated cells.
Drug-Uptake St udies
Exponentially growing cells (5 x 104/dish) were seeded in a Falcon 24 multiplate with 2 ml medium for 48 hours. The medium was then replaced by 1 ml Ham's F-12 medium with 10% serum containing 0.2 uCi ~4C-ACNU (ethylene-~4C-ACNU, specific activity 17 Ci/mg, purity > 85% as determined by thin-layer chromatography),* 0.2 uCi ~H-vinblastine (specific activity 17 Ci/mmole), or 0.02 uCi ~C-Adriamycin (specific activity 56 mCi/mmole), and the cells were incubated further at 37~ At fixed intervals, the medium was removed, and the cells were washed three times with cold PBS at 4~ The washed ceils were solubilized in 1 N NaOH and neutralized with 2 N HCI, and radioactivity was determined in a liquid scintillation spectrometer. The intracellular drug content was expressed as the degradations/rain (dpm)/10 ~ cells.
Drug-EfflzL~ Studies
After 5 x 104 cells had been incubated for 48 hours, they were further incubated at 37~ for 2 hours with 0.2 uCi L4C-ACNU-containing medium, or for 3 hours with 0.2 uCi ~H-vinblastine-containing medium or 0.02 uCi x4C-Adriamycin-containing medium. The drugcontaining medium was then removed, and the cells were washed three times with cold PBS, then resuspended in drug-free medium at 37'C. At fixed intervals, medium was removed, and the cells were washed twice with cold PBS and solubilized with 1 N NaOH. The radioactivity was then measured as described for the * Ethylene-"C-ACNU kindly supplied by Sankyo Co., Tokyo, Japan. influx studies. Effiux ability was expressed as a percent of the initial intracellular drug concentration.
. l.~say O~ G/utathione
Exponentially growing cells (5 x 105) were seeded in 10-cm plastic dishes and trypsinized at the late logarithmic growth phase. These cells were washed twice with cold PBS, resuspended in 5% trichloroacetic acid (TCA) with 5 mM ethylenediaminetetra-acetic acid, and centrifuged at 6000 rpm for 30 minutes at 4~ The TCA was removed, and the supernatant was assayed at least three times for total glutathione content by the glutathione reductase-5,5'-dithiobis-(2-nitrobenzoic acid) recirculating method of Tietze 3~' as modified by Griffith. ~' Statistical analysis of cell survival curves, uptake studies, and total glutathione was performed using Student's t-test.
Results
Cross-Resistance Patterns to Chemicals and Hypertkermia
Patterns of cross-resistance to chemicals are presented in Table 1 . The ACNU-resistant cells of R~, R3, and R~_, were I0.0, 21.0, and 25.2 times more resistant to ACNU, respectively, than the 9L glioma parent cells. These resistant sublines have been maintained in drugfree medium for more than 12 months with a stable resistance to ACNU. Among the alkylating agents studied, a cross-resistance pattern was observed only with the CNU compound methyl-CNU (MCNU): no cross-resistance was observed either with monoalkylating compounds N-methyl-N'-nitro-N-nitrosoguanidine (MNNG), methylnitrosourea (MNU), and ethylmethane sulfonate (EMS) or with bifunctional alkylating compounds (melphalan, mitomycin-C (MMC), and cisplatinum). Inversely, R~ and R~ were more sensitive to cis-platinum than were the parental 9L cells by approximately a factor of two. Moderate cross-resistance of three and sixfold greater was observed among the three resistant cells to Adriamycin, vinblastine, and VP-16 (multidrug-resistance pattern). The minimum concentration of L-ASP that inhibited the growth of parental 9L cells completely was 10 ~ kU/ml, while the minimum concentration that inhibited R~, R~, and R~ cells was 10 -~, 10 -5, and 5 x 10 -5 kU/ml, respectively. Therefore, these resistant cells were more sensitive to L-ASP than were 9L cells by 10.0-, 105-, and 2 x 10-~-fold. The sensitivity of R, cells to hyperthermia was almost the same as that of 9L cells. Both cell lines showed measurable cymtoxicity over 43~
X-Ray and UV Sensitivity
The x-ray survival curves for 9L and resistant cells are shown in Fig. 1 . The curves for R~ and R~: cells had a wider shoulder than the 9L cell curve. The mean (___ standard deviation) D~, was 1.51 -2-_ 0.22 Gy for 9L cells, 1.28 + 0.16 Gy for R~ cells, 1.47 _+ 0.12 Gy for R3 cells, and 1.24 _+ 0.13 Gy for R,2 cells. No statistically significant difference in Do was noted between 9L and the three resistant sublines. The Dq for 9L, R~, R~, and RL~ statistically significant only for R~ cells compared to 9L cells (p < 0.05). Therefore, the UV sensitivity of R, cells was slightly higher than that of 9L cells. Figure 2A shows the uptake and the retention of HC-ACNU of 9L and R3 cells at 37~ and at 4~ At 37~ the ~4C-ACNU uptake of both 9L and R3 cells for up to 120 minutes was greater than at 40C, but no significant difference in uptake existed between the two cells.
Uptake and Efflux Studies
For both 9L and R~ cells, ACNU uptake at 4~ reached a plateau of approximately one-half to one-third the accumulation at 37~
This finding indicates that ACNU uptake is temperature-sensitive. The effiux of t4C-ACNU from 9L arid R3 cells is shown in Fig. 2B . No significant difference was observed between the two cells at any time interval studied (p > 0.1 ).
Uptake of J4C-Adriamycin by cultured 9L cells increased with time under the condition of constant drug exposure (Fig. 2C ). Approximately 4.4 x 103 dpm/106 9L cells was found at 3 hours, while the amount in each cated. Uptake is expressed as dpm/106 cells. Right." Retention ability was examined as follows. After preincubation of cells with 0.2 uCi/ml of 14C-ACNU (B) for 120 minutes, 0.02 t, Ci/ml of ~4C-Adriamycin (D) for 180 minutes, or 0.2 uCi/ ml of ~H-vinblastine (F) for 180 minutes at 37'C or at 4"C, these cells were washed free of the drug and resuspended in fresh medium. Over the next 120 or 180 minutes, intracellular radiolabeled ACNU was measured at fixed intervals. Retention of the radiolabeled drug was expressed as a percent of the initial intracellular concentration. Each point depicts the mean of three separate experiments.
resistant subline was much smaller, and the level reached a plateau (approximately 25% of 9L cell uptake) after 3 hours of incubation; only a marginal increase occurred thereafter. Efflux of ~C-Adriamycin Cross-resistance patterns in ACNU-resistant gliornas after 3 hours of cell incubation with this drug is shown in Fig. 2D . Retained ~4C-Adriamycin in 9L, R~, and Rz2 cells reached a plateau at 15 minutes (approximately 70%, 85%, and 65% of the control level, respectively), whereas in R3, ]4C-Adriamycin decreased gradually to approximately 80% of the control level at 120 minutes. No significant difference was observed between 9L and the resistant subline cells (p > 0. I ).
Intracellular uptake of ~H-vinblastine in 9L cells increased rapidly with time to 7.5 • 103 dpm/106 cells at 3 hours ( Fig. 2E ). In the resistant sublines, uptake was much smaller: the level at 3 hours in R~, R3, and R j2 cells was 40%, 34%, and 22%, respectively, of that in 9L cells. The amount of uptake in each resistant subline was significantly less than that in 9L ceils (p < 0.05), but no significant difference was observed between the three resistant sublines (p > 0.1). A rapid efflux of ~H-vinblastine occurred during incubation for 15 minutes, and about 50% of the labeled drug was lost from the cells (Fig. 2F ). After 120 minutes of incubation, 22% to 40% of the labeled drug had been transported outside the cells. No clear difference in drug effiux was detected between 9L and the resistant sublines. 
Glutathione Levels in Parent and Resistant Sublines
Intracellular total glutathione levels in 9L and resistant sublines in the late logarithmic growth phase were determined (Fig. 3) . The concentration in the parent cells was 5.13 + 1.24 nM/10 ~ cells (mean + standard deviation). In contrast, total glutathione concentrations were significantly higher in R~, R~, and R._~ cells: 9.80 _ 2.51, 8.42 _+ 2.50, and 11.00 _+ 2.92 riM/106 cells, respectively (p < 0.05).
Discussion
Cross-Resistance Patterns of Resistant Sublines
Each of the three ACNU-resistant sublines possessed complete cross-resistance to the CNU compound, MCNU, and moderate cross-resistance to structurally dissimilar drugs (Adriamycin, vinblastine, and VP-16); two subclones also exhibited resistance to x-irradiation with increased Dq. However, none of the sublines developed resistance to any other alkylating agent, whether it was a monofunctional type (MNU, EMS, or MNNG) or bifunctional type (MMC, melphalan, or cisplatinum). Furthermore, each of these lines acquired collateral sensitivity of high magnitude to L-ASP (ranging from 10-fold to 2 x 105-fold that of the parent cells). Relatively little attention has been directed toward the cross-resistance patterns of CNU-resistant cells. 35 Our finding that ACNU resistance was associated with unexpected patterns of altered sensitivity to antineoplastic agents and x-irradiation raised the question as to a rational and effective strategy in response to the acquired CNU resistance. This study is an attempt to clarify the mechanism of this altered sensitivity of the ACNU-resistant sublines.
A CNU Resistance
Uptake and efflux of ACNU of the R3 subline was similar to that of 9L cells, with no significant difference. Therefore, ACNU transport did not correlate with resistance to ACNU. The cross-resistance pattern of the ACNU-resistant sublines to various alkylating agents indicates that the mechanism of ACNU resistance is specific to CNU. O6-alkylguanine-deoxyribonucleic acid (DNA) alkyltransferase (AT), 6'39 which predominantly repairs O~-alkylguanine of DNA formed by the reaction with CNU, has been assumed to play a key role in the repair of lethal interstrand cross-linking formation produced by CNU, 8 ~o.2~.32 and is believed to play an important part in determining the level of sensitivity of cells to CNU. This enzyme is also known to be a major determinant of the sensitivity to monofunctional alkylating agents 32 (MNNG, MNU, and EMS), because these agents produce lethal cell damage by forming only single-strand DNA breaks (O6-alkylguanine))' Nevertheless, the lack of cross-resistance to MNNG and MNU in any of the ACNU-resistant sublines suggests that AT does not play a major role in the acquired ACNU-resistant sublines. Recently, a strong correlation between AT activity and natural resistance to CNU has been demonstrated. 37 However, in acquired CNU-resistant cells, differences in AT activity are not sufficient to explain the degree of acquired resistance. 3~ These findings support the concept that the mechanism of acquired resistance to CNU is not as simple as those of natural resistance.
Role ~f Drug Transport on Multidrug Res&tance
These resistant sublines showed moderate cross-resistance to the nonalkylating agents (Adriamycin, vinblas-tine, and VP-16). This pattern is similar to the multidrug-resistance pattern ~ which usually is observed in cells resistant to Vinca alkaloids or anthracyclines. In these multidrug-resistant cells, increased levels of highmolecular-weight membrane glycoproteins (P170) have been associated with decreased drug accumulation as a result of enhanced drug efflux. '~ Moreover, amplified and over-expressed P170 or homologous genes ~' have been isolated from several multidrug-resistant cell lines. There have been a few reports that similar multidrugresistance patterns could be obtained by selection with an alkylating agenff '~~ however, its mechanism remains unknown. In our study, uptake of radiolabeled Adriamycin and vinblastine was decreased in the resistant sublines compared to 9L cells, but no observed difference was sufficient to elucidate the difference in resistance between the three resistant sublines. Therefore, one of the mechanisms for multidrug resistance in the ACNU-resistant sublines is believed to be impairment of drug accumulation. An effiux study was also carried out, but showed no significant difference between 9L cells and the resistant sublines. Thus, unlike the typical multidrug-resistant cells induced by Vinca alkaloids or anthracyclines, decreased uptake by the ACNU-resistant sublines appears not to be due to increased efflux, so possible mechanisms other than P-glycoprotein need to be suggested.
Collateral Sensitivity lo L-Asparaginase
The most unexpected result in this cross-resistance study was the acquisition of high degrees of collateral sensitivity to L-ASP shared by all three ACNU-resistant sublines. Completely different from ACNU in structure and mechanisms of action, L-ASP decomposes asparagine into aspartic acid, and eventually this enzymatic depletion of asparagine results in cell death. Two enzymes have been identified that could determine a response of cells to L-ASP: they are asparagine synthetase '3 and asparagyl-transfer ribonucleic acid (RNA) synthetase. 2~ We have already confirmed that ACNU-resistant sublines have much lower asparagine synthetase activity than the parent 9L cells (unpublished data). Therefore, this phenomenon is believed to have been induced by the mutagenic action of ACNU. Like other alkylating agents, ACNU has strong mutagenic activity ~~2-~T and is apt to induce 5-fluoro-2,4(lH, 3H)pyrimidinedione (5-FU)-or azaguanine-resistant mutants '7 and increases sister chromatid exchange among lymphoeytes in patients after chemotherapy) 9
Effect of Glutathione on Radioresistance
The acquisition of radioresistance in the ACNUresistant sublines is intriguing. Ionizing radiation and anticancer drugs are two major antineoplastic agents that have been used commonly in combination in the treatment of malignancies. It is ve~ rare for cells made resistant to a chemotherapeutic agent in vitro also to acquire radioresistance. :: Acquisition of radioresistance in the ACNU-resistant subtines suggests common mechanisms underlying both radiation and ACNUresistance. This is especially interesting because the DNA lesions induced by the two agents are differentp ~'~ but little is known about the common DNA repair pathway. A tripeptide thiol, glutathione] 4 is another factor that may play a role in resistance to radiation and ACNU. There has been increasing evidence that cellular glutathione alters the cytotoxicity of alkylating agents such as radiation and hyperthermia. 3~7j ~,25 Glutathione, the chief nonprotein intracellular sulfhydryl, is responsible for a variety of cellular functions, including protection from toxic oxygen species and detoxification of various xenobiotics, mainly through nuc[eophilic thioether formation or oxidation-reduction reactions) In this reaction, glutathione transforms oxidized glutathione by glutathione peroxidase, and oxidized glutathione returns to glutathione by gtutathione reductase. - '4 Total glutathione consists of glutathione and oxidized g]utathione; however, the level of oxidized glutathione is usually less than 5% of glutathione, -'4 so the level of the latter component is considered almost equal to that of total glutathione. For this reason, we determined total glutathione levels only. In this study, the total glutathione level was approximately 2.0, 1.8, and 2.4 times higher in R~, R3, and R3_, cells than in 9L cells (p < 0.05), but R. cells did not become radioresistant, whereas R~ and R~_~ cells did, owing to an increase of D,,. This result may indicate that an increased glutathione level in ACNU-resistant sublines is not directly associated with radioresistance. Glutathione plays an important role in the protection of cells against damage from irradiation and chemotherapeutic drugs, as stated previously. Furthermore, glutathione also participates in drug delivery, -~' the host immune system. -'~ and other metabolic functions. Therefore, the increase of glutathione in ACNU-resistant sublines may not be a cause of radioresistance but it may be the result of these changes. In the current study, we were not able to determine to what degree the elevated glutathione level in the ACNU-resistant sublines affects radiation resistance. Studies to evaluate the effect of increased total glutathione levels in ACNU-resistant sublines on the cross-resistance to ionizing radiation are in progress.
